SURVIVAL ANALYSIS IN PREGNANT WOMEN DIAGNOSED WITH DIABETES MELLITUS AND COVID-19
Article Sidebar
Main Article Content
Abstract
Maternal mortality associated with diabetes mellitus and COVID-19 represents a significant public health problem in Brazil, as gestational diabetes represents a significant risk factor for morbidity and mortality during this period. Furthermore, COVID-19 is a respiratory disease that presents an increase in morbidity and mortality when considering risk factors. This article aims to describe the profile of maternal mortality associated with COVID-19 from 2020 to 2023 in Brazil. This is an epidemiological, analytical, exploratory, and retrospective study with a quantitative approach. The population consisted of deaths among pregnant women diagnosed with diabetes and diagnosed with COVID-19 from 2021 to 2023 in Brazil. Data collection was performed using the influenza epidemiological surveillance information system (SIVEP-GRIPE) from 2021 to 2023, a secondary data source. The results indicated a survival probability of 78.5 in the first trimester, 75.3 in the second trimester, and 74.3 in the third trimester. In other words, the higher the gestational age, the lower the survival rate. It can be concluded that COVID-19 reduces the survival rate in pregnant women living with diabetes mellitus. On the other hand, measures such as adherence to the vaccination schedule and preventive behaviors tend to reduce morbidity and mortality in pregnant women living with diabetes who contract COVID-19.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c). Conjuncture Bulletin (BOCA)
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
ACIP - Advisory Committee On Immunization Practices. “ACIP recommendations”. ACIP [2023]. Available at: . Access at: 01/06/2025.
AMURES - Associação dos Municípios da Região Serrana. Institucional. Lages: AMURES, 2021. Disponível em: . Acesso em: 04/07/2025.
AYALA-RAMIREZ, P. et al. “Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Pregnancy. A Non-systematic Review of Clinical Presentation, Potential Effects of Physiological Adaptations in Pregnancy, and Placental Vascular Alterations”. Frontiers in Physiology, vol. 37, 2022.
BRASIL. Nota Técnica N. 2/2021-SECOVID/GAB/SECOVID/MS. Brasília: Ministério da Saúde, 2021. Disponível em: . Acesso em: 03/06/2025.
BRASIL. Open DataSUS. Brasília: Ministério da Saúde, 2023b. Disponível em: . Acesso em: 03/06/2025.
BRENDOLIN, M. et al. “Severe maternal morbidity and mortality during the COVID-19 pandemic: a cohort study in Rio de Janeiro”. IJID Regions, vol. 6, 2023.
CANALES, I. C. et al. “Prevalência de mortalidade por covid-19 em gestantes acometidas por cardiopatia (2020 A 2023)”. Boletim de Conjuntura (BOCA), vol. 22, n. 65, 2025.
CARBONE, L. et al.” COVID‐19 vaccine and pregnancy outcomes: A systematic review and meta‐analysis”. International Journal of Gynecology and Obstetrics, vol. 159, n. 3, 2022.
CIAPONNI, A. et al. “Safety of COVID-19 vaccines during pregnancy: A systematic review and meta-analysis”. Vaccine, vol. 41, 2023.
COMIT - Covid-19 Maternal Immunization Tracker. “Berman Institute of Bioethics and Center for Immunization Research, Johns Hopkins University”. COMIT [2023]. Disponível em: . Acesso em: 10/07/2025.
DUNWORT, K. et al. “Aesthetic Outcomes in Cleft Care: Exploring Patterns in Patient-Reported Outcomes Across Adolescence”. Plastic and Reconstructive Surgery, vol. 34, 2023
FDA - Federal Drug Administration. Coronavirus (COVID-19) Drugs. Maryland: FDA, 2023. Disponível em: . Acesso em: 08/08/2025.
FIGO - International Federation of Gynecology and Obstetrics. What is COVID-19. London: FIGO, 2023. Disponível em: . Acesso em: 05/03/2025.
FRANCO, V. F. et al. “Unveiling the hidden burden of COVID-19 in Brazil's obstetric population with severe acute respiratory syndrome: A machine learning model”. PLoS One, vol. 22, 2025.
FREIRE, V. A. F. et al. “Associação de fatores biológicos, determinantes sociais de saúde e hospitalização com a mortalidade devido a SRAG/Covid-19”. Revista de Epidemiologia e Controle de Infecção, vol. 15, n. 1, 2025.
FREITAS, C. et al. “COVID-19 Vaccines Confer Protection in Hospitalized Pregnant and Postpartum Women with Severe COVID-19: A Retrospective Cohort Study”. Vaccines, vol. 10, n. 5, 2022.
HUANG, Z. et al. “Proteomic analysis illustrates the potential involvement of motor proteins in cleft palate development”. Scientific Reports, vol. 14, n. 1, 2024.
JAMIESON, D. J.; RASMUSSEN, S. A. “An update on COVID-19 and pregnancy”. American Journal Obstetrics and Gynecology, vol. 226, n. 2, 2022.
MANSSENBURG, B. B.; TAYLOR, J. A. “Discussion: Aesthetic outcomes in cleft care: exploring patterns in patient-reported outcomes across adolescence”. Plastic and Reconstructive Surgery, vol. 154, n. 4, 2024.
MARTINS, M. M. et al.“Adequação da assistência pré-natal durante a pandemia de COVID-19: estudo observacional com mulheres pós-parto”. Revista Brasileira de Ginecologia e Obstetrícia, vol. 44, 2022.
MAZA-ARNEDO, F. et al. “Maternal mortality linked to COVID-19 in Latin America: Results from a multi-country collaborative database of 447 deaths”. The Lancet Regional Health - Americas, vol. 12, 2022.
MICHAEL, A. I. et al. “Preoperative quality of life of patients with cleft lip and palate in Nigeria: a multicentre cross-sectional pilot study”. The Pan African Medical Journal, vol. 48, 2024.
MUPANOMUNDA, M. et al. “Comparison of Severe Maternal Morbidities Associated With Delivery During Periods of Circulation of Specific SARS-CoV-2” Variants. JAMA Network Open, vol. 5, 2022.
NHI - National Institutes Of Health. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines COVID-19: therapeutic management of hospitalized adults with COVID-19. Maryland: NHI, 2022. Disponível em: . Acesso em: 05/03/2025.
OOBR - Observatório Obstétrico Brasileiro. “SRAG: Síndrome respiratória aguda grave em gestantes e puérperas”. OOBR [2023]. Disponível em: . Acesso em: 05/03/2025.
OPAS - Organização Panamericana de Saúde. “OMS declara fim da Emergência de Saúde Pública de Importância Internacional referente à COVID-19”. OPAS [2023]. Disponível em: . Acesso em: 05/03/2025.
ORELLANDA, J. et al. “Excess maternal mortality in Brazil: Regional inequalities and trajectories during the COVID-19 epidemic”. Plos One, vol. 17, n. 10, 2022.
PAGANOTI, C. F. et al. “COVID-19 vaccines confer protection in hospitalized pregnant and postpartum women with severe COVID-19: a retrospective cohort study”. Vaccines, vol. 10, n. 5, 2022.
PINTO, M. M. Caracterização de gestantes com COVID-19 na Serra Catarinense (Dissertação de Mestrado em Ambiente e Saúde). Lages: UNIPLAC, 2023.
PINTO, M. M. et al. “Casos de gestantes com covid-19 e influência das comorbidades nos desfechos gestacionais”. Boletim de Conjuntura (BOCA), vol. 15, n. 45, 2023.
TAKEMOTO, M. L. S. et al. “Maternal mortality and COVID-19”. The Journal of Maternal-Fetal and Neonatal Medicine, vol. 35, n. 12, 2022.